age1
Overview
age1 is a venture capital firm that invests in and supports founders of longevity biotech companies. It focuses on early-stage investments, including pre-seed and seed rounds, in companies developing therapeutics, tools, and technologies that target aging and age-related diseases to extend healthy lifespans. The firm is a successor to The Longevity Fund and was co-founded by Laura Deming (founder of The Longevity Fund) and Dr. Alex Colville.
Portfolio Companies
11
Website
age1.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Loyal | Feb 2026 | Series C | Lead |
| Deciduous Therapeutics | Jul 2019 | Seed | Co-investor |
| Fauna Bio | May 2018 | Seed | Co-investor |
| Rubedo Life Sciences | Dec 2020 | Seed | Co-investor |
| Skeletalis Bio | Nov 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is age1 based?
age1 is headquartered in San Francisco, California, United States.
When was age1 founded?
Founding year information for age1 is not publicly available.
How many portfolio companies does age1 have?
age1 has 11 portfolio companies in Caplight's dataset.
What are some companies in age1's portfolio?
Portfolio companies visible on Caplight include Loyal, Deciduous Therapeutics, Fauna Bio, Rubedo Life Sciences, Skeletalis Bio.
What was age1's most recent investment shown here?
age1's most recent investment in this portfolio sample was in Loyal in 2026.
What sectors does age1 focus on?
age1 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does age1 focus on?
age1 typically invests at the Early stage.